Related Experiment Videos
Megavitamins for minimal brain dysfunction. A placebo-controlled study
Insights
This study found no significant difference in outcomes for children with minimal brain dysfunction given megavitamins versus a placebo. While two children on placebo improved significantly, overall results showed no clear benefit of megavitamins.
Area of Science:
- Pediatric neurology
- Nutritional psychiatry
Background:
- Minimal brain dysfunction (MBD) is a condition affecting children's behavior and learning.
- Investigating non-stimulant interventions like megavitamins is crucial for MBD management.
Purpose of the Study:
- To assess the efficacy of megavitamin supplementation compared to placebo in children with MBD.
- To inform potential alternative treatments for MBD.
Main Methods:
- A randomized controlled trial involving 31 children diagnosed with MBD.
- Participants received either a megavitamin combination or a placebo for two weeks.
- Outcomes were evaluated using blind ratings from parents and teachers.
Main Results:
- No statistically significant difference in improvement was observed between the megavitamin and placebo groups.
- Two children in the placebo group showed substantial improvement, negating the need for stimulant medication.
Conclusions:
- Megavitamin supplementation did not demonstrate a significant therapeutic effect in this group of children with MBD.
- Further research may be needed to explore specific nutrient roles or different MBD populations.
Abstract:
Preliminary to a stimulant comparison study, 31 children with minimal brain dysfunction randomly received either placebo or a megavitamin combination. During a two-week trial, only two children responded so well that stiumlants were not considered necessary; both were in the placebo group. Change scores from pretest to posttest on four blind ratings by teachers and parents did not show a significant difference between the placebo and vitamin groups.